Ilagan, Venjie A.

HRN: 27-77-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/11/2025
09/18/2025
IV
115mg
Q8hours
T/c Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines